GREENHAWT MATTHEW J. (Chief Medical Officer) received a stock award from AQUESTIVE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2026ACC: 0001214659-26-003134
Officer· Chief Medical Officer
Since Mar 2026
+125K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
125K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
New position
3/9/2026
0.00→75K
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | A · Award | +75K | — | — | New position | 0.00 | 75K |
| Total | +75K | $0.00 | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
4.29
Held after
50K
Exercisable
—
3/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock50K shares | 3/9/2026 | A · Award | +50K | 4.29 | — | 50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported